(Q34173419)

31 July 2017

Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy (English)

1 reference

31 July 2017

1 reference

3

Douglas T Ross

1 reference

31 July 2017

John M S Bartlett

1

1 reference

31 July 2017

Jeremy Thomas

2

1 reference

31 July 2017

Robert S Seitz

4

1 reference

31 July 2017

Brian Z Ring

5

1 reference

31 July 2017

Rodney A Beck

6

1 reference

31 July 2017

Hans Christian Pedersen

7

1 reference

31 July 2017

Alison Munro

8

1 reference

31 July 2017

Ian H Kunkler

9

1 reference

31 July 2017

Fiona M Campbell

10

1 reference

31 July 2017

Wilma Jack

11

1 reference

31 July 2017

Gillian R Kerr

12

1 reference

31 July 2017

Laura Johnstone

13

1 reference

31 July 2017

David A Cameron

14

1 reference

31 July 2017

Udi Chetty

15

1 reference

31 July 2017

8 July 2010

1 reference

31 July 2017

Breast Cancer Research

1 reference

31 July 2017

12

1 reference

31 July 2017

4

1 reference

31 July 2017

R47

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2604

31 July 2017

0 references

cites work

Tamoxifen: the drug that came in from the cold

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

External quality assurance of HER2 FISH and ISH testing: three years of the UK national external quality assurance scheme

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Gene expression profiling predicts clinical outcome of breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Molecular portraits of human breast tumours

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

Pathological prognostic factors in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2949634

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

5 July 2018

1 reference

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

21 January 2018

1 reference

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

21 January 2018

1 reference

Histological grading of invasive breast carcinoma--a simplification of existing methods in a large conservation series with long-term follow-up.

21 January 2018

1 reference

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20615243

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR2604

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference